Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:methylphenidate
|
| gptkbp:approvedBy |
gptkb:Canada
|
| gptkbp:broadcastOn |
controlled substance
|
| gptkbp:form |
extended-release capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biphentin
|
| gptkbp:manufacturer |
gptkb:Purdue_Pharma
|
| gptkbp:mechanismOfAction |
stimulant
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
abdominal pain
headache insomnia decreased appetite |
| gptkbp:usedFor |
gptkb:attention_deficit_hyperactivity_disorder
|
| gptkbp:bfsParent |
gptkb:methylphenidate
|
| gptkbp:bfsLayer |
6
|